Realtime Device-Driven Escalation-Avoidance for Heart Failure

Coredio is a software as a medical device, using AI and physics, and existing wearables for non-invasive Heart Failure management. It is offered as SaaS platform to improve cardiac patient outcomes. It enables effective medication titration for cardiologists/nurses, dramatically reducing readmissions (including 30-day readmits).

Read more

Product Features

Coredio is designed to easily integrate in clinicians workflows to improve patient care outcomes

Realtime Device-Driven Escalation Avoidance for Heart Failure

Coredio is a software as a medical device, using AI and physics, and existing wearables for non-invasive Heart Failure management. It is offered as SaaS platform to improve cardiac patient outcomes. It enables effective medication titration for cardiologists/nurses, dramatically reducing readmissions (including 30-day readmits).

Read more

Product Features

Coredio is designed to easily integrate in clinicians workflows to improve patient care outcomes

Workflow

About The Platform

Personalized Cardiovascular Monitoring with CoreDio

Patient Eligibility: CoreDio is visioned to be prescribed by a cardiologist for patients with cardiovascular conditions such as heart failure upon their initial visit.

One-Time Calibration Process: A 5 minutes non-invasive one-time calibration is performed, leveraging the patient’s PPG, ECG, BP and EHR history combined with existing or new ultrasound.
Once calibrated, CoreDio’s precision remains tailored to the individual patient for a subsequent up to 3 years.

On-Demand Monitoring: After one-time calibration, Cardiologists and HF nurses can use Coredio platform to seamlessly connect with PPG+ECG and cuff BP devices to monitor patient’s intra-cardiac LVEDP, CVP,  CI and SVR. The platform’s allows for monitoring within clinical settings or at-home.

See Demo
Contact Us
Workflow

About The Platform

Personalized Cardiovascular Monitoring with CoreDio

Patient Eligibility: CoreDio is visioned to be prescribed by a cardiologist for patients with cardiovascular conditions such as heart failure upon their initial visit.

One-Time Calibration Process: A 5 minutes non-invasive one-time calibration is performed, leveraging the patient’s PPG, ECG, BP and EHR history combined with existing or new ultrasound.
Once calibrated, CoreDio’s precision remains tailored to the individual patient for a subsequent up to 3 years.

On-Demand Monitoring: After one-time calibration, Cardiologists and HF nurses can use Coredio platform to seamlessly connect with PPG+ECG and cuff BP devices to monitor patient’s intra-cardiac LVEDP, CVP,  CI and SVR. The platform’s allows for monitoring within clinical settings or at-home.

See Demo
Contact Us

How It Works

In order to manage patient medication post-discharge, cardiologists and HF nurses need to monitor Intra-cardiac pressure, Cardiac Output (CO), and Central BP.

1-time calibration: At the initial visit, the doctor connects patient to routine checkup tools and uses Coredio’s platform to make it patient-specific.

Read More
Contact Us

How It Works

In order to manage patient medication post-discharge, cardiologists and HF nurses need to monitor Intra-cardiac pressure, Cardiac Output (CO), and Central BP.

1-time calibration: At the initial visit, the doctor connects patient to routine checkup tools and uses Coredio’s platform to make it patient-specific.

Read More
Contact Us

Accuracy

The Sensitivity Of The Device in Finding Accurate Statistics

Accuracy & Validation

  • Validation: Tested at partner hospitals
  • Standard Comparison: Strong correlation with Right and Left Heart Cath and echo
  • Patient Trials: Studies ongoing at multiple sites

Future Milestones:

  • Regulatory: Clear FDA pathway.
  • Expansion: Kicked-off 4 internal review board (IRB) approved studies.

Precision

CoreDio’s technology features:

  • Intra-cardiac pressure monitoring (in validation)
  • On-demand CI/LVEDP/CVP/SVR trends across week days
  • Catheter-level accuracy

Accuracy

The Sensitivity Of The Device in Finding Accurate Statistics

Accuracy & Validation

  • Validation: Tested at partner hospitals
  • Standard Comparison: Strong correlation with Right and Left Heart Cath and echo
  • Patient Trials: Studies ongoing at multiple sites

Future Milestones:

  • Regulatory: Clear FDA pathway.
  • Expansion: Kicked-off 4 internal review board (IRB) approved studies.

Property Accuracy

CoreDio’s technology features:

  • Intra-cardiac pressure monitoring (in validation)
  • On-demand CI/LVEDP/CVP/SVR trends across week days
  • Catheter-level accuracy

Testimonials

Testimonials from patients and doctors

See More

Cardiologist #1

Head of Cardiology (EP)

By potentially averting re-admission hospitalizations, it not only ensures better patient care but also can result in significant savings – approximately $20k per instance.

Cardiologist #2

Heart Failure Specialist

Noninvasive measurement of intra-cardiac pressures can elevate our remote patient monitoring programs, by enabling guideline-directed medication therapy for HF patients.

Cardiologist #3

General Adult Cardiologist

In our high-volume cardiac clinic, where we perform >100 caths daily, the immediate value of CoreDio platform is undeniable. We’d integrate it without hesitation if available.

Partners